Artist DENIAL Shares Experience with Cannabis and Mercedes Lawsuit

in Culture

Since 1999, Canadian pop and mural artist Daniel Joseph Bombardier, better known by his artistic alter ego DENIAL, has been creating aerosol and stencil artworks that critique contemporary politics, capitalism, consumerism and the human condition. But one of DENIAL’s latest pieces, commissioned for and by High Times, is a more personal project. Part of a series titled “Shelf Medication,” DENIAL created a giant capsule that looks like a painted pill branded with the High Times logo. But while “Shelf Medication” wants to draw attention to the way people obsess over brands and become addicted to products, DENIAL’s High Times capsule is more about how people are starting to view and use cannabis as a medicine.

Overdose Collection by artist, Enjoy Denial. Aerosol on wood panel. 2019

High Times caught up with Bombardier, who just wrapped up a “Part Art Part Party” at his studio, celebrating the launch of a limited edition English beer DENIAL produced some artwork for. We asked him about the role cannabis plays in his creative process, how it treats his insomnia and why he’s being sued by Mercedes-Benz.

Canadian Mural Artist DENIAL Cured His Insomnia with Cannabis Oil

Photo Courtesy of Enjoy Denial

DENIAL’s “Shelf Medication” piece for High Times isn’t meant to suggest that people are addicted to weed or overly obsessed with the world’s greatest weed media company. Instead, it’s an expression of Bombardier’s personal experience with cannabis and the massive social movement that’s embracing it, after years of criminalization and denial, as a safe and effective medicine.

For at least a decade, Bombardier suffered from severe insomnia. Despite trying everything from sleeping pills, special pillows, sleep meds, Ambien and drinking any and everything, nothing worked. “It’s the type of mind I have. I just won’ …

Read More

Author: Adam Drury / High Times

Leave a Reply

Your email address will not be published.


Latest from Culture

0 $0.00
Go to Top